Report Detail

According to our (Global Info Research) latest study, the global Demineralized Bone Matrix and Demineralized Allograft market size was valued at US$ 662 million in 2025 and is forecast to a readjusted size of US$ 1026 million by 2032 with a CAGR of 6.5% during review period.
Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins. These growth factors modulate the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. As a result of the demineralization process, DBM is more biologically active than undemineralized bone grafts; conversely the mechanical properties are significantly diminished.
The demineralized bone matrix market is primarily driven by the increasing demand for bone graft substitutes in orthopedic and dental surgeries. Demineralized bone matrix (DBM) is derived from human or animal bones and contains growth factors and proteins that promote bone regeneration and healing. The rising prevalence of musculoskeletal disorders, trauma, and dental conditions fuels the adoption of DBM as an effective and biocompatible bone graft material. However, the market also faces challenges, including the need for standardized and high-quality DBM products to ensure consistent clinical outcomes. Variability in DBM processing methods and composition may impact its efficacy and safety. Moreover, strict regulatory requirements and ethical concerns related to the sourcing and processing of DBM can pose challenges for manufacturers in the market.
This report is a detailed and comprehensive analysis for global Demineralized Bone Matrix and Demineralized Allograft market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Demineralized Bone Matrix and Demineralized Allograft market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Demineralized Bone Matrix and Demineralized Allograft market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Demineralized Bone Matrix and Demineralized Allograft market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Demineralized Bone Matrix and Demineralized Allograft market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Demineralized Bone Matrix and Demineralized Allograft
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Demineralized Bone Matrix and Demineralized Allograft market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, J &J (DePuy Synthes), SeaSpine, Xtant Medical, Zimmer Biomet, Stryker, Straumann, Wright Medical Group, Hans Biomed, Arthrex, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Demineralized Bone Matrix and Demineralized Allograft market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Gel
Putty
Putty with Chips
Others
Market segment by Application
Dental Surgery
Spine Surgery
Trauma Surgery
Major players covered
Medtronic
J &J (DePuy Synthes)
SeaSpine
Xtant Medical
Zimmer Biomet
Stryker
Straumann
Wright Medical Group
Hans Biomed
Arthrex
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Demineralized Bone Matrix and Demineralized Allograft product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Demineralized Bone Matrix and Demineralized Allograft, with price, sales quantity, revenue, and global market share of Demineralized Bone Matrix and Demineralized Allograft from 2021 to 2026.
Chapter 3, the Demineralized Bone Matrix and Demineralized Allograft competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Demineralized Bone Matrix and Demineralized Allograft breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Demineralized Bone Matrix and Demineralized Allograft market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Demineralized Bone Matrix and Demineralized Allograft.
Chapter 14 and 15, to describe Demineralized Bone Matrix and Demineralized Allograft sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Demineralized Bone Matrix and Demineralized Allograft Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Gel
    • 1.3.3 Putty
    • 1.3.4 Putty with Chips
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Demineralized Bone Matrix and Demineralized Allograft Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Dental Surgery
    • 1.4.3 Spine Surgery
    • 1.4.4 Trauma Surgery
  • 1.5 Global Demineralized Bone Matrix and Demineralized Allograft Market Size & Forecast
    • 1.5.1 Global Demineralized Bone Matrix and Demineralized Allograft Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Demineralized Bone Matrix and Demineralized Allograft Sales Quantity (2021-2032)
    • 1.5.3 Global Demineralized Bone Matrix and Demineralized Allograft Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Medtronic
    • 2.1.1 Medtronic Details
    • 2.1.2 Medtronic Major Business
    • 2.1.3 Medtronic Demineralized Bone Matrix and Demineralized Allograft Product and Services
    • 2.1.4 Medtronic Demineralized Bone Matrix and Demineralized Allograft Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Medtronic Recent Developments/Updates
  • 2.2 J &J (DePuy Synthes)
    • 2.2.1 J &J (DePuy Synthes) Details
    • 2.2.2 J &J (DePuy Synthes) Major Business
    • 2.2.3 J &J (DePuy Synthes) Demineralized Bone Matrix and Demineralized Allograft Product and Services
    • 2.2.4 J &J (DePuy Synthes) Demineralized Bone Matrix and Demineralized Allograft Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 J &J (DePuy Synthes) Recent Developments/Updates
  • 2.3 SeaSpine
    • 2.3.1 SeaSpine Details
    • 2.3.2 SeaSpine Major Business
    • 2.3.3 SeaSpine Demineralized Bone Matrix and Demineralized Allograft Product and Services
    • 2.3.4 SeaSpine Demineralized Bone Matrix and Demineralized Allograft Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 SeaSpine Recent Developments/Updates
  • 2.4 Xtant Medical
    • 2.4.1 Xtant Medical Details
    • 2.4.2 Xtant Medical Major Business
    • 2.4.3 Xtant Medical Demineralized Bone Matrix and Demineralized Allograft Product and Services
    • 2.4.4 Xtant Medical Demineralized Bone Matrix and Demineralized Allograft Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Xtant Medical Recent Developments/Updates
  • 2.5 Zimmer Biomet
    • 2.5.1 Zimmer Biomet Details
    • 2.5.2 Zimmer Biomet Major Business
    • 2.5.3 Zimmer Biomet Demineralized Bone Matrix and Demineralized Allograft Product and Services
    • 2.5.4 Zimmer Biomet Demineralized Bone Matrix and Demineralized Allograft Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Zimmer Biomet Recent Developments/Updates
  • 2.6 Stryker
    • 2.6.1 Stryker Details
    • 2.6.2 Stryker Major Business
    • 2.6.3 Stryker Demineralized Bone Matrix and Demineralized Allograft Product and Services
    • 2.6.4 Stryker Demineralized Bone Matrix and Demineralized Allograft Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Stryker Recent Developments/Updates
  • 2.7 Straumann
    • 2.7.1 Straumann Details
    • 2.7.2 Straumann Major Business
    • 2.7.3 Straumann Demineralized Bone Matrix and Demineralized Allograft Product and Services
    • 2.7.4 Straumann Demineralized Bone Matrix and Demineralized Allograft Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Straumann Recent Developments/Updates
  • 2.8 Wright Medical Group
    • 2.8.1 Wright Medical Group Details
    • 2.8.2 Wright Medical Group Major Business
    • 2.8.3 Wright Medical Group Demineralized Bone Matrix and Demineralized Allograft Product and Services
    • 2.8.4 Wright Medical Group Demineralized Bone Matrix and Demineralized Allograft Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Wright Medical Group Recent Developments/Updates
  • 2.9 Hans Biomed
    • 2.9.1 Hans Biomed Details
    • 2.9.2 Hans Biomed Major Business
    • 2.9.3 Hans Biomed Demineralized Bone Matrix and Demineralized Allograft Product and Services
    • 2.9.4 Hans Biomed Demineralized Bone Matrix and Demineralized Allograft Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Hans Biomed Recent Developments/Updates
  • 2.10 Arthrex
    • 2.10.1 Arthrex Details
    • 2.10.2 Arthrex Major Business
    • 2.10.3 Arthrex Demineralized Bone Matrix and Demineralized Allograft Product and Services
    • 2.10.4 Arthrex Demineralized Bone Matrix and Demineralized Allograft Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Arthrex Recent Developments/Updates

3 Competitive Environment: Demineralized Bone Matrix and Demineralized Allograft by Manufacturer

  • 3.1 Global Demineralized Bone Matrix and Demineralized Allograft Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Demineralized Bone Matrix and Demineralized Allograft Revenue by Manufacturer (2021-2026)
  • 3.3 Global Demineralized Bone Matrix and Demineralized Allograft Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Demineralized Bone Matrix and Demineralized Allograft by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Demineralized Bone Matrix and Demineralized Allograft Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Demineralized Bone Matrix and Demineralized Allograft Manufacturer Market Share in 2025
  • 3.5 Demineralized Bone Matrix and Demineralized Allograft Market: Overall Company Footprint Analysis
    • 3.5.1 Demineralized Bone Matrix and Demineralized Allograft Market: Region Footprint
    • 3.5.2 Demineralized Bone Matrix and Demineralized Allograft Market: Company Product Type Footprint
    • 3.5.3 Demineralized Bone Matrix and Demineralized Allograft Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Demineralized Bone Matrix and Demineralized Allograft Market Size by Region
    • 4.1.1 Global Demineralized Bone Matrix and Demineralized Allograft Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Demineralized Bone Matrix and Demineralized Allograft Consumption Value by Region (2021-2032)
    • 4.1.3 Global Demineralized Bone Matrix and Demineralized Allograft Average Price by Region (2021-2032)
  • 4.2 North America Demineralized Bone Matrix and Demineralized Allograft Consumption Value (2021-2032)
  • 4.3 Europe Demineralized Bone Matrix and Demineralized Allograft Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Demineralized Bone Matrix and Demineralized Allograft Consumption Value (2021-2032)
  • 4.5 South America Demineralized Bone Matrix and Demineralized Allograft Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Demineralized Bone Matrix and Demineralized Allograft Sales Quantity by Type (2021-2032)
  • 5.2 Global Demineralized Bone Matrix and Demineralized Allograft Consumption Value by Type (2021-2032)
  • 5.3 Global Demineralized Bone Matrix and Demineralized Allograft Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Demineralized Bone Matrix and Demineralized Allograft Sales Quantity by Application (2021-2032)
  • 6.2 Global Demineralized Bone Matrix and Demineralized Allograft Consumption Value by Application (2021-2032)
  • 6.3 Global Demineralized Bone Matrix and Demineralized Allograft Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Demineralized Bone Matrix and Demineralized Allograft Sales Quantity by Type (2021-2032)
  • 7.2 North America Demineralized Bone Matrix and Demineralized Allograft Sales Quantity by Application (2021-2032)
  • 7.3 North America Demineralized Bone Matrix and Demineralized Allograft Market Size by Country
    • 7.3.1 North America Demineralized Bone Matrix and Demineralized Allograft Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Demineralized Bone Matrix and Demineralized Allograft Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Demineralized Bone Matrix and Demineralized Allograft Sales Quantity by Type (2021-2032)
  • 8.2 Europe Demineralized Bone Matrix and Demineralized Allograft Sales Quantity by Application (2021-2032)
  • 8.3 Europe Demineralized Bone Matrix and Demineralized Allograft Market Size by Country
    • 8.3.1 Europe Demineralized Bone Matrix and Demineralized Allograft Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Demineralized Bone Matrix and Demineralized Allograft Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Demineralized Bone Matrix and Demineralized Allograft Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Demineralized Bone Matrix and Demineralized Allograft Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Demineralized Bone Matrix and Demineralized Allograft Market Size by Region
    • 9.3.1 Asia-Pacific Demineralized Bone Matrix and Demineralized Allograft Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Demineralized Bone Matrix and Demineralized Allograft Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Demineralized Bone Matrix and Demineralized Allograft Sales Quantity by Type (2021-2032)
  • 10.2 South America Demineralized Bone Matrix and Demineralized Allograft Sales Quantity by Application (2021-2032)
  • 10.3 South America Demineralized Bone Matrix and Demineralized Allograft Market Size by Country
    • 10.3.1 South America Demineralized Bone Matrix and Demineralized Allograft Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Demineralized Bone Matrix and Demineralized Allograft Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Market Size by Country
    • 11.3.1 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Demineralized Bone Matrix and Demineralized Allograft Market Drivers
  • 12.2 Demineralized Bone Matrix and Demineralized Allograft Market Restraints
  • 12.3 Demineralized Bone Matrix and Demineralized Allograft Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Demineralized Bone Matrix and Demineralized Allograft and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Demineralized Bone Matrix and Demineralized Allograft
  • 13.3 Demineralized Bone Matrix and Demineralized Allograft Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Demineralized Bone Matrix and Demineralized Allograft Typical Distributors
  • 14.3 Demineralized Bone Matrix and Demineralized Allograft Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Demineralized Bone Matrix and Demineralized Allograft. Industry analysis & Market Report on Demineralized Bone Matrix and Demineralized Allograft is a syndicated market report, published as Global Demineralized Bone Matrix and Demineralized Allograft Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Demineralized Bone Matrix and Demineralized Allograft market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report